Nipro (TSE:8086) Inventories, Finished Goods : 円151,726 Mil (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Nipro Inventories, Finished Goods?

Nipro's quarterly finished goods increased from Jun. 2023 (円140,426 Mil) to Sep. 2023 (円149,723 Mil) and increased from Sep. 2023 (円149,723 Mil) to Dec. 2023 (円151,726 Mil).

Nipro's annual finished goods increased from Mar. 2022 (円118,315 Mil) to Mar. 2023 (円137,774 Mil) and increased from Mar. 2023 (円137,774 Mil) to Mar. 2024 (円150,391 Mil).

Nipro Inventories, Finished Goods Historical Data

The historical data trend for Nipro's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nipro Inventories, Finished Goods Chart

Nipro Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Inventories, Finished Goods

Get a 7-Day Free Trial

106,284.00

113,109.00

118,315.00

137,774.00

150,391.00

Nipro Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial															137,774.00	140,426.00	149,723.00	151,726.00	150,391.00

Nipro Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Nipro (TSE:8086) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nipro Corp (TSE:8086) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

5FA:Germany

Address

3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510

Website

http://www.nipro.co.jp

Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.

Nipro (TSE:8086) Headlines

No Headlines